0001127602-24-018325.txt : 20240610 0001127602-24-018325.hdr.sgml : 20240610 20240610215810 ACCESSION NUMBER: 0001127602-24-018325 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240607 FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farrell Michael J. CENTRAL INDEX KEY: 0001485164 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 241034520 MAIL ADDRESS: STREET 1: C/O REMED INC STREET 2: 9001 SPECTRUM CTR. BLVD. CITY: SAN DIEGO, STATE: CA ZIP: 92123 FORMER NAME: FORMER CONFORMED NAME: Farrell Michael DATE OF NAME CHANGE: 20100224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-06-07 0000943819 RESMED INC RMD 0001485164 Farrell Michael J. RESMED INC. 9001 SPECTRUM CENTER BLVD SAN DIEGO CA 92123 1 Chief Executive Officer 1 ResMed Common Stock 2024-06-07 4 M 0 14683 84.98 A 455482 D ResMed Common Stock 2024-06-07 4 S 0 14683 211.6556 D 440799 D ResMed Common Stock 0 I Lisette and Michael Farrell Foundation ResMed Common Stock 4090 I Lisette and Michael Farrell Family Trust ResMed Common Stock Options 84.98 2024-06-07 4 M 0 14683 0 D 2018-11-11 2024-11-16 ResMed Common Stock 14683 73415 D The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024. This transaction was executed in multiple trades at prices ranging from $210.58 - $213.86. The price reported above reflects the weighted average sale price. Includes 46.9596 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan. Represents date options first became exercisable. Options vest 1/3 per year. Michael J. Farrell, Chief Executive Officer 2024-06-10